Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells

Journal of Virology

Volumn 87, Issue 6, 2013, Pages 3261-3270

  Ioannidis, Ioannis ^a   Ye, Fang ^a   McNally, Beth ^a   Willette, Meredith ^a   Flaño, Emilio ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; INTERLEUKIN 8; LAMBDA INTERFERON; STAT1 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME REGULATION; EPITHELIUM CELL; EX VIVO STUDY; HUMAN; HUMAN CELL; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRACHEA;

CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; INTERFERON TYPE I; INTERLEUKINS; ORTHOMYXOVIRIDAE; TOLL-LIKE RECEPTORS; TRACHEA;

EID: 84874679317     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01956-12     Document Type: Article

References (64)

1. Bals R, Hiemstra PS. 2004. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23:327-333.
2. Diamond G, Legarda D, Ryan LK. 2000. The innate immune response of the respiratory epithelium. Immunol. Rev. 173:27-38.
3. Humlicek AL, Manzel LJ, Chin CL, Shi L, Excoffon KJ, Winter MC, Shasby DM, Look DC. 2007. Paracellular permeability restricts airway epithelial responses to selectively allow activation by mediators at the basolateral surface. J. Immunol. 178:6395-6403.
4. Kato A, Schleimer RP. 2007. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr. Opin. Immunol. 19:711-720.
5. Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC. 2007. Epithelium: at the interface of innate and adaptive immune responses. J. Allergy Clin. Immunol. 120:1279-1284.
6. Shaykhiev R, Bals R. 2007. Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis. J. Leukoc. Biol. 82:1-15.
7. Shornick LP, Wells AG, Zhang Y, Patel AC, Huang G, Takami K, Sosa M, Shukla NA, Agapov E, Holtzman MJ. 2008. Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection. J. Immunol. 180:3319-3328.
8. Mayer AK, Muehmer M, Mages J, Gueinzius K, Hess C, Heeg K, Bals R, Lang R, Dalpke AH. 2007. Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J. Immunol. 178: 3134-3142.
9. Muir A, Soong G, Sokol S, Reddy B, Gomez MI, Van Heeckeren A, Prince A. 2004. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 30:777-783.
10. Platz J, Beisswenger C, Dalpke A, Koczulla R, Pinkenburg O, Vogelmeier C, Bals R. 2004. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J. Immunol. 173:1219-1223.
11. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. 2004. Activation of airway epithelial cells by Toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol. 31:358-364.
12. Lopez-Souza N, Dolganov G, Dubin R, Sachs LA, Sassina L, Sporer H, Yagi S, Schnurr D, Boushey HA, Widdicombe JH. 2004. Resistance of differentiated human airway epithelium to infection by rhinovirus. Am. J. Physiol. 286:L373-L381.
13. Ueno K, Koga T, Kato K, Golenbock DT, Gendler SJ, Kai H, Kim KC. 2008. MUC1 mucin is a negative regulator of Toll-like receptor signaling. Am. J. Respir. Cell Mol. Biol. 38:263-268.
14. Ciencewicki JM, Brighton LE, Jaspers I. 2009. Localization of type I interferon receptor limits interferon-induced TLR3 in epithelial cells. J. Interferon Cytokine Res. 29:289-297.
15. Dvorak A, Tilley AE, Shaykhiev R, Wang R, Crystal RG. 2011. Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome? Am. J. Respir. Cell Mol. Biol. 44:465-473.
16. Fulcher ML, Gabriel S, Burns KA, Yankaskas JR, Randell SH. 2005. Well-differentiated human airway epithelial cell cultures. Methods Mol. Med. 107:183-206.
17. Rowe RK, Brody SL, Pekosz A. 2004. Differentiated cultures of primary hamster tracheal airway epithelial cells. In Vitro Cell. Dev. Biol. 40:303-311.
18. Noppert SJ, Fitzgerald KA, Hertzog PJ. 2007. The role of type I interferons in TLR responses. Immunol. Cell Biol. 85:446-457.
19. Biron CA. 2001. Interferons alpha and beta as immune regulators: a new look. Immunity 14:661-664.
20. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
21. Der SD, Zhou A, Williams BR, Silverman RH. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 95:15623-15628.
22. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFNlambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69-77.
23. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4:63-68.
24. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. 2006. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80:4501-4509.
25. Levy DE, Marie IJ, Durbin JE. 2011. Induction and Function of type I and III interferon in response to viral infection. Curr. Opin. Virol. 1:476-486.
26. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR. 2008. An important role for type III interferon (IFN-λ/IL- 28) in TLR-induced antiviral activity. J. Immunol. 180:2474-2485.
27. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 4:e1000017. doi:10.1371/journal.ppat .1000017.
28. Jewell NA, Cline T, Mertz SE, Smirnov SV, Flano E, Schindler C, Grieves JL, Durbin RK, Kotenko SV, Durbin JE. 2010. Lambda interferon is the predominant interferon induced by influenzaAvirus infection in vivo. J. Virol. 84:11515-11522.
29. Ioannidis I, McNally B, Willette M, Peeples ME, Chaussabel D, Durbin JE, Ramilo O, Mejias A, Flano E. 2012. Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J. Virol. 86:5422-5436.
30. Weslow-Schmidt JL, Jewell NA, Mertz SE, Simas JP, Durbin JE, Flano E. 2007. Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection. J. Virol. 81:9778-9789.
31. Flano E, Kayhan B, Woodland DL, Blackman MA. 2005. Infection of dendritic cells by a gamma2-herpesvirus induces functional modulation. J. Immunol. 175:3225-3234.
32. Blasius AL, Beutler B. 2010. Intracellular Toll-like receptors. Immunity 32:305-315.
33. Hertzog PJ, O'Neill LA, Hamilton JA. 2003. The interferon in TLR signaling: more than just antiviral. Trends Immunol. 24:534-539.
34. Parker D, Prince A. 2011. Type I interferon response to extracellular bacteria in the airway epithelium. Trends Immunol. 32:582-588.
35. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. 2005. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23:307-336.
36. Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M. 2006. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2:e53. doi:10.1371/journal.ppat.0020053.
37. Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U. S. A. 103:8459-8464.
38. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28.
39. Rajan JV, Warren SE, Miao EA, Aderem A. 2010. Activation of the NLRP3 inflammasome by intracellular poly I:C. FEBS Lett. 584:4627-4632.
40. Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T. 2002. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293:1364-1369.
41. Hacker H, Mischak H, Miethke T, Liptay S, Schmid R, Sparwasser T, Heeg K, Lipford GB, Wagner H. 1998. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by nonspecific endocytosis and endosomal maturation. EMBO J. 17:6230-6240.
42. Macfarlane DE, Manzel L. 1998. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J. Immunol. 160:1122-1131.
43. Yi AK, Tuetken R, Redford T, Waldschmidt M, Kirsch J, Krieg AM. 1998. CpG motifs in bacterial DNA activate leukocytes through the pHdependent generation of reactive oxygen species. J. Immunol. 160:4755-4761.
44. Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD, Millar AB. 2004. Expression of functional Toll-like receptor- 2 and -4 on alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 31:241-245.
45. Greene CM, Carroll TP, Smith SG, Taggart CC, Devaney J, Griffin S, O'Neill JS, McElvaney NG. 2005. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J. Immunol. 174: 1638-1646.
46. Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F, van Bruggen R, Tschopp J. 2007. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J. Histochem Cytochem. 55:443-452.
47. Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippenstiel S, Suttorp N, Wolff T. 2007. IFN-β induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol. 9:930-938.
48. Uehara A, Fujimoto Y, Fukase K, Takada H. 2007. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2, to produce antimicrobial peptides, but not proinflammatory cytokines. Mol. Immunol. 44:3100-3111.
49. Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, Mah S, Han SH, Lee H, Paik SG, Lee JO. 2009. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31:873-884.
50. Longhi MP, Trumpfheller C, Idoyaga J, Caskey M, Matos I, Kluger C, Salazar AM, Colonna M, Steinman RM. 2009. Dendritic cells require a systemic type I interferon response to mature and induce CD4 Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206:1589-1602.
51. Ritter M, Mennerich D, Weith A, Seither P. 2005. Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response. J. Inflamm. (Lond.) 2:16.
52. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M. 2005. Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280:5571-5580.
53. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, Hartshorn KL, Mason RJ. 2009. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-λ1) in response to influenza A infection. J. Immunol. 182:1296-1304.
54. Khaitov MR, Laza-Stanca V, Edwards MR, Walton RP, Rohde G, Contoli M, Papi A, Stanciu LA, Kotenko SV, Johnston SL. 2009. Respiratory virus induction of alpha-, beta-, and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 64:375-386.
55. Osterlund PI, Pietila TE, Veckman V, Kotenko SV, Julkunen I. 2007. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-λ) genes. J. Immunol. 179:3434-3442.
56. Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, Brown EG, Holtzman MJ, Brody SL. 2006. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J. Virol. 80:7469-7480.
57. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, Si-Tahar M. 2007. Cutting edge: influenza A virus activates TLR3- dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178:3368-3372.
58. Teng F, Slavik V, Duffy KE, San Mateo L, Goldschmidt R. 2010. Toll-like receptor 3 is involved in airway epithelial cell response to nontypeable Haemophilus influenzae. Cell. Immunol. 260:98-104.
59. Pyles RB, Jezek GE, Eaves-Pyles TD. 2010. Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection. Infect. Immun. 78:1700-1710.
60. Joshi AD, Schaller MA, Lukacs NW, Kunkel SL, Hogaboam CM. 2008. TLR3 modulates immunopathology during a Schistosoma mansoni eggdriven Th2 response in the lung. Eur. J. Immunol. 38:3436-3449.
61. Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, Lukacs NW, Hogaboam CM, Kunkel SL. 2008. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 205:2609-2621.
62. Kariko K, Buckstein M, Ni H, Weissman D. 2005. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23:165-175.
63. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D. 2004. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279:12542-12550.
64. Torres D, Dieudonne A, Ryffel B, Vilain E, Si-Tahar M, Pichavant M, Lassalle P, Trottein F, Gosset P. 2010. Double-stranded RNA exacerbates pulmonary allergic reaction through TLR3: implication of airway epithelium and dendritic cells. J. Immunol. 185:451-459.